Circulating endothelial cell levels correlate with proinflammatory cytokine increase in the acute phase of thermal injury

Journal of Burn Care and Rehabilitation

Volumn 26, Issue 5, 2005, Pages 422-429

  Kowal Vern, Areta ^a   Webster, Scot D ^b   Rasmasubban, Suresh ^c   Casey, Larry ^c   Bauer, Kenneth ^b   Latenser, Barbara A ^e   Rubin, David B ^d  

^a Jr Hospital of Cook County   (United States)

^b ChromaVision Medical Systems Inc   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^e PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; ARTICLE; CYTOMETRY; ENDOTHELIUM CELL; HUMAN; LUNG BURN; PNEUMONIA; THERMAL INJURY;

ADULT; BIOLOGICAL MARKERS; BURNS, INHALATION; CASE-CONTROL STUDIES; CYTOKINES; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PNEUMONIA; PROGNOSIS;

EID: 26444487566     PISSN: 02738481     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.bcr.0000176881.94641.bd     Document Type: Article

References (44)

1. Harrison HN. Respiratory tract injury, pathophysiology and response to therapy among burned patients. Ann N Y Acad Sci 1968;150:627-38.
2. Pruitt Jr., BA, Flemma RJ, Di Vincenti FC, et al.. Pulmonary complications in burn patients: a comparative study of 697 patients. J Thorac Cardiovasc Surg 1970;59:7-20.
3. American Burn Association Fact Sheet. Available at: http:// www.ameriburn.org/pub/BurnIncidenceFactSheet.htm.
4. Gartner R, Griffe O, Captier G, et al.. Acute respiratory insufficiency in burn patients from smoke inhalation. Pathol Biol (Paris) 2002;50:118-26.
5. Shimokawa H. Primary endothelial dysfunction: Atherosclerosis. J Mol Cell Cardiol 1999;31:23-37.
6. Wort SJ, Evans TW. The role of the endothelium in modulating vascular control in sepsis and related conditions. Br Med Bull 1999;55:30-48.
7. Cines HB, Pollak KS, Buck CA, et al.. Endothelial cells in physiology and the pathophysiology of vascular disorders. Blood 1998;91:3527-61.
8. Dignat-Georgc F, Sampol J. Circulating endothelial cells in vascular disorders: new insights into an old concept. Eur J Haematol 2000;65:215-20.
9. Sinzinger H, Fitscha P, Kritz H, et al.. Prostaglandin E1 decreases circulating endothelial cells. Prostaglandins 1996; 51:61-8.
10. Sowemimo-Coker SO, Meiselman HJ, Francis Jr. RB Increased circulating endothelial cells in sickle cell crisis. Am J Hematol 1989;31:263-5.
11. Zhu Z. Changes in circulating endothelial cells in patients with essential hypertension. Zhonghua Xin Xue Guan Bing Za Zhi 1991;19:217-8.
12. Percivalle E, Revello MG, Vago L, et al.. Circulating endothelial giant cells permissive tor human cytomegalovirus (HCMV) are detected in disseminated HCMV infections with organ involvement. J Clin Invest 1993;92:663-70.
13. Mutin M, Canavy I, Blann A, et al.. Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells. Blood 1999;93:2951-58.
14. Mutunga M, Fulton B, Bullock R, et al.. Circulating endothelial cells in patients with septic shock. Am J Respir Crit Care Med 2001;163:195-200.
15. Clancy RM. Circulating endothelial cells and vascular injury in systemic lupus erythematosus. Curr Rheumatol Rep 2000; 2:39-43.
16. Gill M, Dias S, Hattori K, et al.. Vascular trauma induces rapid but transient mobilization of VEGFR 2(+)AC133(+) endothelial precursor cells. Circ Res 2001;88:167-74.
17. Grad S, Ertel W, Keel M, et al.. Strongly enhanced serum levels of vascular endothelial growth factor (VEGF) after polytrauma and burn. Clin Chem Lab Med 1998;36:379-83.
18. Rodvien R. Hematologic observations made in patients with acute respiratory distress syndrome in the cooperative ECMO project. Art Organs 1978;2:12-8.
19. Davies MG, Hagen PO. Systemic inflammatory response syndrome. Br J Surg 1997;84:920-35.
20. Demling RH. The modern version of adult respiratory distress syndrome. Ann Rev Med 1995;46:193-202.
21. Li Q, Qian G, Chen Z. A preliminary study on the markers of pulmonary vascular endothelial cells in patients with ARDS. Zhonghua Jie He He Hu Xi Za Zhi 1999;22:533-5.
22. Ramasubban S, Kellar S, Webster S, et al. Circulating endothelial cells in patients with acute lung injury [abstract]. American Thoracic Society, 99th International Conference, Seattle, WA, 2003. Am J Resp Crit Care Med 2003;167.
23. Solovey A, Lin T, Browne P, et al.. Circulating activated endothelial cells in sickle cell anemia. N Eng J Med 1997; 337:1584-90.
24. Segal MS, Bihorac A, Koc M. Circulating endothelial cells: tea leaves for renal disease. Am J Renal Physiol 2002;283: F11-9.
25. Malone DL, Kuhls D, Napolitano LM, et al.. Back to basics: validation of the admission systemic inflammatory response score in predicting outcome in trauma. J Trauma 2001;51: 458-63.
26. Muehlstedt SG, Richardson CJ, Lyte M, et al.. Systemic and pulmonary effector cell function after injury. Crit Care Med 2002;30:1322-6.
27. Muehlstedt SG, Lyte M, Rodgriguez JL. Increased IL-10 production and HLA DR suppression in the lungs of injured patients precede the development of nosocomial pneumonia. Shock 2002;17:443-50.
28. Messingham KA, Heinrich SA, Schilling KM, et al.. Interleukin-4 treatment restores cellular immunity after ethanol exposure and burn injury. Alcohol Clin Exp Res 2002;26:519-26.
29. Yeh FL, Lin WL, Shen HD. Changes in circulating levels of an anti-inflammatory cytokine interleukin-10 in burned patients. Burns 2000;26:454-9.
30. Jobin N, Carrel D, Bernier J. Increased serum-soluble interleukin-2 receptor in burn patients: characterization and effects on the immune system. Hum Immunol 2000;61: 233-46.
31. Call DR, Remick DG. Low molecular weight heparin is associated with greater cytokine production in a stimulated whole blood model. Shock 1998;10:192-7.
32. Pedersen M, Bruunsgaard H, Weis N, et al.. Circulating levels of TNF-alpha and IL-6 relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-two diabetes. Mech Aging Dev 2003;124:495-502.
33. Kowal-Vern A, Gamelli RL, Walenga J, et al.. Interleukin-6 and Interleukin-2 in relation to burn wound size in the acute phase of thermal injury. J Am Coll Surg 1994;78:357-62.
34. 1esterase inhibitor. J Burn Care Rehabil 1997;18:99-103.
35. Dehne MG, Sablotzki A, Hoffmann A, et al. Alterations of acute phase reaction and cytokine production in patients following severe burn injury. Burns 2002;28:535-42.
36. Cid MC. Endothelial cell biology, perivascular inflammation, and vasculitis. Cleveland Clin J Med 2002;69 Suppl 2:SII45-9.
37. Kowal-Vern A, Walenga J, Gamelli R, et al. The effect of burn wound size on hemostasis: a correlation of the hemostatic changes to the clinical state. J Trauma 1992;33:50-7.
38. Kowal-Vern A, McGill V, Walenga JM, et al. AT concentrate-infusions are safe and effective in thermally injured patients. J Burn Care Rehabil 2000;21:115-27.
39. Opal SM, Kessler CM, Roemisch J, et al. Antithrombin, heparin and heparan sulfate. Crit Care Med 2002;30(Suppl): S325-31.
40. Solovey A, Gui L, Ramakrishna S, et al. Sickle cell anemia as a possible state of enhanced anti-apoptotic tone: survival effect of vascular endothelial growth factor on circulating and unanchored endothelial cells. Blood 1999;93:3824-30.
41. Rompais H, Chagraoui J, Canron X, et al. Human endothelial cells derived from circulating progenitors display specific functional properties compared with mature vessel wall endothelial cells. Blood 2004;103:2577-84.
42. Ogura H, Tanaka H, Koh T, et al. Enhanced production of endothelial microparticles with increased binding to leukocytes in patients with severe systemic inflammatory response syndrome. J Trauma 2004;56:823-31.
43. Woywodt A, Bahlmann FH, de Groot K, Haller H, Haubitz. Circulating endothelial cells: life, death, detachment and repair of the endothelial cell layer. Nephrol Dial Transplant 2002;17:1728-30.
44. Iwami Y, Masuda H, Asahara T. Endothelial progenitor cells: past, state of the art, and future. J Cell Mol Med 2004;8: 488-97.